Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 22195 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Utilizing a Targeted Media Campaign 

and Community Health Workers to 

Increase Breast and Cervical Cancer 

Screening Among Muslim Women, SIP 

15–004.’’ 

Contact Person for More Information: 

Brenda Colley Gilbert, Ph.D., M.S.P.H., 

Director, Extramural Research Program 

Operations and Services, CDC, 4770 

Buford Highway NE., Mailstop F–80, 

Atlanta, Georgia 30341, Telephone: 

(770) 488–6295, BJC4@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–09084 Filed 4–20–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–15–15ZT; Docket No. CDC–2015– 

0023] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing efforts to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on the proposed information 

collection request for the Performance 

Measurement and Program Evaluation 

of the Autism and Developmental 

Disabilities Monitoring Network 

(ADDM). CDC seeks to collect 

performance monitoring and program 

evaluation data from all sites 

participating in the ADDM network. 

DATES: Written comments must be 

received on or before June 22, 2015. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2015– 

0023 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulation.gov. Follow the instructions 

for submitting comments. 

• Mail: Leroy A. Richardson, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE., 

MS–D74, Atlanta, Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

Regulations.gov. 

Please note: All public comment should be 

submitted through the Federal eRulemaking 

portal (Regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact the Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE., MS–D74, Atlanta, 

Georgia 30329; phone: 404–639–7570; 

Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Under the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3501–3520), 

Federal agencies must obtain approval 

from the Office of Management and 

Budget (OMB) for each collection of 

information they conduct or sponsor. In 

addition, the PRA also requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each new proposed 

collection, each proposed extension of 

existing collection of information, and 

each reinstatement of previously 

approved information collection before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, we are publishing this 

notice of a proposed data collection as 

described below. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology; and (e) estimates of capital 

or start-up costs and costs of operation, 

maintenance, and purchase of services 

to provide information. Burden means 

the total time, effort, or financial 

resources expended by persons to 

generate, maintain, retain, disclose or 

provide information to or for a Federal 

agency. This includes the time needed 

to review instructions; to develop, 

acquire, install and utilize technology 

and systems for the purpose of 

collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information, to search 

data sources, to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. 

Proposed Project 

Performance Measurement and 

Program Evaluation of the Autism and 

Developmental Disabilities Monitoring 

Network (ADDM)—New—National 

Center on Birth Defects and 

Developmental Disabilities (NCBDDD), 

Centers for Disease Control and 

Prevention (CDC) is a new Information 

Collection Request. 

Background and Brief Description 

In January 2015, CDC launched a new 

phase of funding for its autism spectrum 

disorder (ASD) surveillance program 

through a new cooperative agreement: 

‘‘Enhancing Public Health Surveillance 

of Autism Spectrum Disorder and Other 

Developmental Disabilities through the 

Autism and Developmental Disabilities 

Monitoring (ADDM) Network’’ under 

the Funding Opportunity 

Announcement (FOA) DD15–1501. 

Through this cooperative agreement, 

funding is provided to enhance tracking 

at eight existing sites and to launch two 

new sites. Awards were made to state/ 

local health departments and/or their 

designated representatives, including 

Colorado Department of Public Health 

and Environment, Johns Hopkins 

University, Rutgers University, 

University of Arizona, University of 


tkelley on DSK3SPTVN1PROD with NOTICES
22196 Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 

Arkansas for Medical Sciences, 

University of North Carolina at Chapel 

Hill, University of Minnesota, 

University of Wisconsin-Madison, 

Vanderbilt University, and Washington 

University in St. Louis. Four sites 

received funding to carry out 

Component A, which focuses on 

surveillance of ASD and either cerebral 

palsy or intellectual disability among 8- 

year-olds. Six sites received funding to 

carry out both Component A as well as 

Component B, which focuses on 

surveillance of ASD among 4-year-olds. 

In addition to the sites funded under the 

cooperative agreement, CDC also 

administers a site in Atlanta, Georgia, 

commonly known as the Metropolitan 

Atlanta Developmental Disabilities 

Surveillance Program (MADDSP). CDC requests OMB approval to collect 

performance monitoring and program 

evaluation information from all sites 

participating in the Autism and 

Developmental Disabilities Monitoring 

Network (including the site 

administered by CDC). Over the course 

of the four-year funding cycle, each site 

will submit a Checklist, Worksheets, 

and Performance Measures every six 

month and two-year intervals. The 

Checklist, Worksheets, and Performance 

Measures will be submitted to CDC by 

completing a Microsoft Excel-based data 

collection tool and uploading the 

information to a secure, passwordprotected FTP site. By developing a 

user-friendly data collection tool in 

Microsoft Excel, CDC anticipates that 

the reporting and tracking burden for 

awardees will be reduced due to: (1) 

awardees’ familiarity with the software, 

which reduces training burden; and (2) 

the compatibility of the templates with 

other record keeping processes that are 

already in place for many awardees. 

CDC staff and contractors will be 

responsible for converting each 

awardee’s submissions into a secure 

Microsoft Access-based system for 

reporting and analysis. CDC anticipates 

that respondent burden will be slightly 

higher at the initial six-month 

submission and will also be slightly 

higher for sites completing Component 

A&B compared to just Component A. 

The information to be collected will 

help CDC and awardees assure 

compliance with cooperative agreement 

requirements, support program 

evaluation efforts, and obtain 

information needed to respond to 

inquiries about program activities and 

program impact from Congress and 

other stakeholders. 

OMB approval is requested for three 

years. Participation is required as a 

condition of cooperative agreement 

funding. There are no costs to 

respondents other than their time. The 

total estimated burden hours are 125. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Component A only (initial six-month 

submission).

Checklist ........................................... 5 1 3/60 1 

Worksheets ...................................... 5 1 1.5 8 

Performance Measures .................... 5 1 30/60 3 

Component A&B (initial six-month 

submission).

Checklist ........................................... 6 1 3/60 1 

Worksheets ...................................... 6 1 2 12 

Performance Measures .................... 6 1 4/60 4 

Component A only (subsequent sixmonth and two-year submissions).Checklist ........................................... 5 5 3/60 1 

Worksheets ...................................... 5 5 1 25 

Performance Measures .................... 5 5 18/60 8 

Component A&B (subsequent sixmonth and two-year submissions).Checklist ........................................... 6 5 3/60 2 

Worksheets ...................................... 6 5 1.5 45 

Performance Measures .................... 6 5 30/60 15 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–09087 Filed 4–20–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Effectiveness of Teen 

Pregnancy Prevention Program Designed 

specifically for Young Males, DP15–007, 

initial review. 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on April 14, 2015 Volume 80, 

Number 71, pages 19989. The title of the 

Special Emphasis Panel should read as 

above and time and date should read as 

follows: 

TIME AND DATE: 9:00 a.m.–6:00 p.m., 

April 7–8, 2015 (Closed). 

FOR FURTHER INFORMATION CONTACT: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F46, Atlanta, Georgia 30341, 

Telephone: (770) 488–3585, EEO6@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–09083 Filed 4–20–15; 8:45 am] 

BILLING CODE 4163–18–P 


tkelley on DSK3SPTVN1PROD with NOTICES